Table 1 Characteristics of the 1631 HIV-positive patients enrolled in the Zemio HIV cohort, Central African Republic from October 2011–May 2017. Interquartile range = IQR, ART = antiretroviral therapy, OIs = opportunistic infections. Loss to follow up is defined as patients not present for an appointment > 12 months before the end of the program

Total patients enrolled in the Zemio HIV cohort

1631 (4107 person-years at risk)

Patients enrolled on ART

1491/1631 (91.4%)

Female patients

1147/1631 (70.3%)

Median age at first appointment (IQR)

29 years (22, 37)

Deaths

148

Loss to follow up

183

CD4 cell count/μl, baseline (IQR), n = 1017

268 (148, 427)

CD4 cell count/μl, 6 months (IQR), n = 442

403 (240, 634)

CD4 cell count/μl, 12 months (IQR), n = 321

433 (264, 636)

Clinical Stage 1 OIs at baseline

241/1628 (14.8%)

Clinical Stage 2 OIs at baseline

403/1628 (24.7%)

Clinical Stage 3 OIs at baseline

789/1628 (48.5%)

Clinical Stage 4 OIs at baseline

195/1628 (12.0%)

Occupation: Infants/ Pupil / Student

148/1628 (9.1%)

Occupation: Farmers / Fishermen / Domestic

1272/1628 (78.1%)

Occupation: Small commerce

139/1628 (8.5%)

Occupation: Civil servant/ official

26/1628 (1.6%)

Occupation: Other /not recorded

43/1628 (2.6%)